Cargando…

A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment

This study investigated the efficiency and safety of imatinib in the lower dose (300 mg/d) in patients with gastrointestinal stromal tumor (GIST) who cannot tolerate imatinib in the standard dose (400 mg/d). Steady-state imatinib trough concentration (Cmin) values in 18 patients with GIST who were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yuan, Xiang, Jin, Tang, Sumin, Chen, Jiaju, Yu, Qin, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266004/
https://www.ncbi.nlm.nih.gov/pubmed/27930532
http://dx.doi.org/10.1097/MD.0000000000005488

Ejemplares similares